Navigation Links
Johnson & Johnson Recall of DePuy Hip Devices: Lewitt Hackman Files Suit
Date:1/31/2011

LOS ANGELES, Jan. 31, 2011 /PRNewswire/ -- Attorneys at Lewitt, Hackman, Shapiro, Marshall & Harlan, a southern California law firm, filed a lawsuit regarding a Johnson & Johnson recall of DePuy metal on metal hip replacement devices. The firm filed the suit against DePuy Orthopedics, Inc. and its parent company Johnson & Johnson, Inc., on January 12, 2011 on behalf of a Los Angeles client. The lawsuit alleges DePuy and Johnson & Johnson designed, manufactured and sold a defective, prosthetic orthopedic implant.

The client, who had to undergo a second complicated hip surgery to replace the defective implant is represented by Attorneys Andrew L. Shapiro, Thomas Cecil, and David B. Bobrosky at Lewitt Hackman. The personal injury attorneys say that in addition to intense pain from the failure of the device which caused a decline in walking and other physical abilities, the client may still suffer from potential metal poisoning and other complications.

According to an August, 2010 article in The New York Times, surgeons implanted about 93,000 ASR XL Acetabular Systems used in traditional hip replacements, and ASR Hip Resurfacing Systems in partial hip replacements, internationally.

The Johnson & Johnson recall was announced nearly two years after the Food and Drug Administration started receiving complaints about the total hip replacement and hip resurfacing devices.  According to The New York Times article, DePuy estimates about 12 to 13 percent of the patients who have the metal on metal hip replacements need a second replacement operation within five years of receiving an ASR implant.

"DePuy's reaction before the recall to the mounting evidence of serious problems with its ASR XL Modular Acetabular Cup System and the DePuy ASR Hip Resurfacing System appears less than forthright," stated attorney Shapiro, adding, "DePuy's questionable pre-recall conduct should certainly make anyone with a DePuy hip implant device think twice about further trusting DePuy to voluntarily pay for all costs of a second surgery and related damages."

Many orthopedic surgeons complain that the hip implant devices are designed improperly, and are extremely difficult to position. Additionally, the very components of the device – cobalt and chrome – also may cause health issues, as the metal on metal wears down within the body.

If you would like to speak with the Los Angeles attorneys handling this case, or if you or someone you know has suffered hip surgery complications related to this Johnson & Johnson recall, please contact Attorneys Andrew Shapiro, Thomas Cecil or David Bobrosky at Lewitt Hackman: 818-907-3223.Media Representatives should call:Chris Podbielski818-907-3271http://www.lewitthackman.com/personal-injury.html
'/>"/>

SOURCE Lewitt Hackman
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Johnson & Johnson to Provide Webcast Presentation of Tapentadol Phase 3 Clinical Data Presented at American Pain Societys Annual Meeting
2. Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R)
3. Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries
4. Johnson & Johnson Announces Support for Kohl-Grassley Physician Payments Sunshine Act of 2009
5. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
6. Palomar to Commercialize FDA Cleared Over-The-Counter Home Use Wrinkle Treatment Laser Device Without Johnson & Johnson
7. U.S. Files Suit Against Johnson & Johnson For Paying Kickbacks to Nations Largest Nursing Home Pharmacy
8. EF Johnson Technologies Announces Third Quarter Results
9. Emerging Agents from Theravance/Astellas, Johnson & Johnson/Basilea and Forest/Astrazeneca/Takeda Will Drive Modest Growth in the MRSA Drug Market Through 2018
10. Johnson & Johnson to Participate in the 30th Annual Cowen and Company Health Care Conference
11. Two Johnson & Johnson Subsidiaries to Pay Over $81 Million to Resolve Allegations of Off-Label Promotion of Topamax
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly and ... will present new data for galcanezumab and lasmiditan, two ... the International Headache Society (IHC) taking place Sept. 7-10 ... Lilly will highlight new, long-term data from an open-label ... of galcanezumab (120 mg and 240 mg) for the ...
(Date:9/5/2017)... , Sept. 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... has successfully concluded its meeting with the U.S. Food ... oral insulin formulation. ... the regulatory pathway for submission of ORMD-0801, would be ...
(Date:8/29/2017)... , Aug. 29, 2017 ivWatch, LLC, the leading provider ... infiltrations, announced it has been awarded an Innovative Technology contract from ... the country. ... device to aid in the early detection of peripheral IV infiltration ... The Innovative Technology contract ...
Breaking Medicine Technology:
(Date:9/22/2017)... ... 22, 2017 , ... Silicon Valley startup Enke Life has ... Their electric toothbrushes aggressively attack oral bacteria by reducing dental plaque and other ... edge Enke technology with a premium timeless design, they want to redefine the ...
(Date:9/22/2017)... ... September 22, 2017 , ... Egg ... life. Although frozen embryos have a slight statistical advantage for live births, frozen ... a wonderful opportunity for women undergoing medical treatment or who are concerned about ...
(Date:9/21/2017)... ... September 21, 2017 , ... Process Capability Indices for ... 3:00 p.m. ET, http://www.fdanews.com/processcapabilityindices      , Quality in device ... of The Quality System Regulation (§820.250), and Devicemakers find themselves staring at a ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... of a new member survey conducted by the International Society of Hair ... from 2014 to 2016 rose 60 percent, with 635,189 procedures performed in 2016. ...
(Date:9/21/2017)... ... 21, 2017 , ... Innovatum will demonstrate capabilities of fully ... Conference 2017 in Chicago, IL on October 17-19, 2017. This unique development addresses ... patient safety. , Microscan , a global technology leader in barcoding, ...
Breaking Medicine News(10 mins):